HELİCOBACTER PYLORI SEROPREVALANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME

Cilt: 19 Sayı: 1 29 Nisan 2014
PDF İndir
EN

HELİCOBACTER PYLORI SEROPREVALANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME

Öz

BACKGROUND:

Hypoxemia related conditions is associated with an increased risk of gastric damage. Helicobacter pylori (H.pylori) infection also causes gastric damage and affects approximately 40 million individuals in Turkey. Obstructive sleep apnea syndrome (OSAS) is a sleep disorder and is characterized by episodic upper airway obstruction during sleep. It is associated with oxyhemoglobin desaturations, hypoxemia and discontinuation of sleep. However, there are a few data in the field of H.pylori prevalence among patients with OSAS which is linked to tissue hypoxemia. The aim of the current study was to investigate the link between H.pylori infection and OSAS.

METHODS:

Between February 2011 and February 2012, faeces was collected from OSAS patients ( n=24; 12 female) and healthy individuals (n=100, 50 female) and analysed using the Helicobacter pylori Stool Antigen Test. OSAS was detected with polysomnography in connection with disease symptoms and findings. All data was recorded on SPSS and analysed with chi-square test.

RESULTS:

Among 24 patients with OSAS, 12 (50%) of them had a positive result for H.pylori fecal test. In control group (100 subjects), H.pylori fecoprevalance was only 15%. H.pylori antibody seropositivity was significantly higher in patients with OSAS compared to control patients (p<0.001). Consistent with recent epidemiologic studies to date, seroprevalence of H.pylori was found higher than normal subjects.

CONCLUSIONS:

Seroprevalance of H.pylori detected with fecal test were significantly higher in patients with OSAS. OSAS is related to presence of H.pylori. A positive correlation between the H.pylori infection and OSAS might be hypothesized. This may be due to gastric damage due to OSAS-related hypoxemia.

Keywords: OSAS, H.pylori, Stool Antigen Test.

Anahtar Kelimeler

Kaynakça

  1. Silva JM, Villares CA, Monteiro Mdo S, et al. Validation of a rapid stool antigen test for diagnosis of Helicobacter pylori infection. Rev Inst Med Trop Sao Paulo 2010; 52: 125-128.
  2. Goodwin CS, Mendall MM, Northfield TC. Helicobacter pylori infection. Lancet 1997; 349: 2652
  3. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
  4. Ferretti A, Giampiccolo P, Cavalli A, et al, Expiratory flow limitation and orthopnea in massively obese subjects. Chest 2001; 119: 1401-1408.
  5. Newman AB, Foster G, Givelber R, et al. Progression and regression of sleep-disordered breathing with changes in weight: The Sleep Heart Health Study. Arch Intern Med 2005; 165: 2408-2413.
  6. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82: 1313-1316.
  7. Wessendorf TE, Thilman AF, Wang YM, et al. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000; 162: 2039-2042.
  8. Geiser T, Buck F, Meyer BJ, et al. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 2002; 69: 229-234.

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yayımlanma Tarihi

29 Nisan 2014

Gönderilme Tarihi

10 Şubat 2013

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2014 Cilt: 19 Sayı: 1

Kaynak Göster

APA
Gultepe, B., Günbatar, H., & Dülger, A. C. (2014). HELİCOBACTER PYLORI SEROPREVALANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME. EASTERN JOURNAL OF MEDICINE, 19(1), 13-15. https://izlik.org/JA74CP76GX
AMA
1.Gultepe B, Günbatar H, Dülger AC. HELİCOBACTER PYLORI SEROPREVALANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME. EASTERN JOURNAL OF MEDICINE. 2014;19(1):13-15. https://izlik.org/JA74CP76GX
Chicago
Gultepe, Bilge, Hülya Günbatar, ve Ahmet Cumhur Dülger. 2014. “HELİCOBACTER PYLORI SEROPREVALANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME”. EASTERN JOURNAL OF MEDICINE 19 (1): 13-15. https://izlik.org/JA74CP76GX.
EndNote
Gultepe B, Günbatar H, Dülger AC (01 Nisan 2014) HELİCOBACTER PYLORI SEROPREVALANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME. EASTERN JOURNAL OF MEDICINE 19 1 13–15.
IEEE
[1]B. Gultepe, H. Günbatar, ve A. C. Dülger, “HELİCOBACTER PYLORI SEROPREVALANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME”, EASTERN JOURNAL OF MEDICINE, c. 19, sy 1, ss. 13–15, Nis. 2014, [çevrimiçi]. Erişim adresi: https://izlik.org/JA74CP76GX
ISNAD
Gultepe, Bilge - Günbatar, Hülya - Dülger, Ahmet Cumhur. “HELİCOBACTER PYLORI SEROPREVALANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME”. EASTERN JOURNAL OF MEDICINE 19/1 (01 Nisan 2014): 13-15. https://izlik.org/JA74CP76GX.
JAMA
1.Gultepe B, Günbatar H, Dülger AC. HELİCOBACTER PYLORI SEROPREVALANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME. EASTERN JOURNAL OF MEDICINE. 2014;19:13–15.
MLA
Gultepe, Bilge, vd. “HELİCOBACTER PYLORI SEROPREVALANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME”. EASTERN JOURNAL OF MEDICINE, c. 19, sy 1, Nisan 2014, ss. 13-15, https://izlik.org/JA74CP76GX.
Vancouver
1.Bilge Gultepe, Hülya Günbatar, Ahmet Cumhur Dülger. HELİCOBACTER PYLORI SEROPREVALANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME. EASTERN JOURNAL OF MEDICINE [Internet]. 01 Nisan 2014;19(1):13-5. Erişim adresi: https://izlik.org/JA74CP76GX